Is It Possible for Children in Duchenne Muscular Dystrophy to Preserve Cardiac Function with Medical Assistance?

In patients with Duchenne muscular dystrophy (DMD), death secondary to cardiac or respiratory failure typically occurs in the second or third decade without treatment. Although cardiac dysfunction is treated with standard heart-failure strategies, it remains insufficient in DMD children. The purpose...

Full description

Bibliographic Details
Main Authors: Han Geul Kim, Lucy Youngmin Eun, Han Ki Park
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/7/11/249
_version_ 1797547124351565824
author Han Geul Kim
Lucy Youngmin Eun
Han Ki Park
author_facet Han Geul Kim
Lucy Youngmin Eun
Han Ki Park
author_sort Han Geul Kim
collection DOAJ
description In patients with Duchenne muscular dystrophy (DMD), death secondary to cardiac or respiratory failure typically occurs in the second or third decade without treatment. Although cardiac dysfunction is treated with standard heart-failure strategies, it remains insufficient in DMD children. The purpose of this study was to evaluate the efficiency of cardiac medication and noninvasive ventilator support in DMD cardiomyopathy children with analyzing echocardiographic data. Forty-eight DMD children patients were included and divided into 2 groups by left ventricular (LV) ejection fraction (EF) at the time of initial treatment. Group 1: LV EF ≥ 45% and Group 2: LV EF < 45%. <i>p</i>-values were calculated using a Linear mixed model to estimate the association between cardiac medications and echocardiographic measurements. Before and after cardiac medications, the change values were significantly different in interventricular septal thickness at end diastole (IVSd), interventricular septal thickness at end systole (IVSs), left ventricular internal diameter end systole (LVIDs), left ventricular posterior wall thickness end diastole (LVPWd), ejection fraction (EF), fractional shortening (FS), deceleration time (DT), DT slope, Lat A’ and Lat E/E’ (<i>p</i> < 0.05). Group 2 patients revealed to take more kinds of cardiac medications than Group 1 (<i>p</i> < 0.05) including ACEIs, beta-blocker, and inotropics, then LV EF was better preserved in Group 2 than Group 1. It is certainly helpful to take individualized medical combination therapy including inotropic agents for cardiomyopathy in DMD children patients with EF < 45%.
first_indexed 2024-03-10T14:38:45Z
format Article
id doaj.art-46f7230a5a0342edabf492e577d48a5c
institution Directory Open Access Journal
issn 2227-9067
language English
last_indexed 2024-03-10T14:38:45Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Children
spelling doaj.art-46f7230a5a0342edabf492e577d48a5c2023-11-20T21:55:15ZengMDPI AGChildren2227-90672020-11-0171124910.3390/children7110249Is It Possible for Children in Duchenne Muscular Dystrophy to Preserve Cardiac Function with Medical Assistance?Han Geul Kim0Lucy Youngmin Eun1Han Ki Park2Division of Pediatric Cardiology, Department of Pediatrics, Yonsei University College of Medicine, Seoul 03722, KoreaDivision of Pediatric Cardiology, Department of Pediatrics, Yonsei University College of Medicine, Seoul 03722, KoreaDivision of Cardiovascular Surgery, Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul 03722, KoreaIn patients with Duchenne muscular dystrophy (DMD), death secondary to cardiac or respiratory failure typically occurs in the second or third decade without treatment. Although cardiac dysfunction is treated with standard heart-failure strategies, it remains insufficient in DMD children. The purpose of this study was to evaluate the efficiency of cardiac medication and noninvasive ventilator support in DMD cardiomyopathy children with analyzing echocardiographic data. Forty-eight DMD children patients were included and divided into 2 groups by left ventricular (LV) ejection fraction (EF) at the time of initial treatment. Group 1: LV EF ≥ 45% and Group 2: LV EF < 45%. <i>p</i>-values were calculated using a Linear mixed model to estimate the association between cardiac medications and echocardiographic measurements. Before and after cardiac medications, the change values were significantly different in interventricular septal thickness at end diastole (IVSd), interventricular septal thickness at end systole (IVSs), left ventricular internal diameter end systole (LVIDs), left ventricular posterior wall thickness end diastole (LVPWd), ejection fraction (EF), fractional shortening (FS), deceleration time (DT), DT slope, Lat A’ and Lat E/E’ (<i>p</i> < 0.05). Group 2 patients revealed to take more kinds of cardiac medications than Group 1 (<i>p</i> < 0.05) including ACEIs, beta-blocker, and inotropics, then LV EF was better preserved in Group 2 than Group 1. It is certainly helpful to take individualized medical combination therapy including inotropic agents for cardiomyopathy in DMD children patients with EF < 45%.https://www.mdpi.com/2227-9067/7/11/249Duchenne muscular dystrophychildrencardiomyopathyheart failureechocardiographymedication
spellingShingle Han Geul Kim
Lucy Youngmin Eun
Han Ki Park
Is It Possible for Children in Duchenne Muscular Dystrophy to Preserve Cardiac Function with Medical Assistance?
Children
Duchenne muscular dystrophy
children
cardiomyopathy
heart failure
echocardiography
medication
title Is It Possible for Children in Duchenne Muscular Dystrophy to Preserve Cardiac Function with Medical Assistance?
title_full Is It Possible for Children in Duchenne Muscular Dystrophy to Preserve Cardiac Function with Medical Assistance?
title_fullStr Is It Possible for Children in Duchenne Muscular Dystrophy to Preserve Cardiac Function with Medical Assistance?
title_full_unstemmed Is It Possible for Children in Duchenne Muscular Dystrophy to Preserve Cardiac Function with Medical Assistance?
title_short Is It Possible for Children in Duchenne Muscular Dystrophy to Preserve Cardiac Function with Medical Assistance?
title_sort is it possible for children in duchenne muscular dystrophy to preserve cardiac function with medical assistance
topic Duchenne muscular dystrophy
children
cardiomyopathy
heart failure
echocardiography
medication
url https://www.mdpi.com/2227-9067/7/11/249
work_keys_str_mv AT hangeulkim isitpossibleforchildreninduchennemusculardystrophytopreservecardiacfunctionwithmedicalassistance
AT lucyyoungmineun isitpossibleforchildreninduchennemusculardystrophytopreservecardiacfunctionwithmedicalassistance
AT hankipark isitpossibleforchildreninduchennemusculardystrophytopreservecardiacfunctionwithmedicalassistance